New York State Common Retirement Fund’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-57,831
Closed -$1.59M 3634
2021
Q2
$1.59M Sell
57,831
-3,969
-6% -$78K ﹤0.01% 2003
2021
Q1
$1.02M Hold
61,800
﹤0.01% 2123
2020
Q4
$1.14M Buy
61,800
+15,400
+33% +$276K ﹤0.01% 1985
2020
Q3
$632K Hold
46,400
﹤0.01% 2110
2020
Q2
$831K Buy
46,400
+21,800
+89% +$329K ﹤0.01% 1964
2020
Q1
$245K Sell
24,600
-7,200
-23% -$59K ﹤0.01% 2368
2019
Q4
$259K Buy
31,800
+1,800
+6% +$16.6K ﹤0.01% 2617
2019
Q3
$297K Hold
30,000
﹤0.01% 2573
2019
Q2
$379K Buy
30,000
+27,500
+1,100% +$290K ﹤0.01% 2515
2019
Q1
$25K Hold
2,500
﹤0.01% 3127
2018
Q4
$19K Buy
+2,500
New +$18.3K ﹤0.01% 3161

New York State Common Retirement Fund's TBIO Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 57,831 shares — an estimated $1.59M sold.

New York State Common Retirement Fund first reported a position in TBIO in Q4 2018 and held it in 11 quarters. The position peaked at $1.59M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • New York State Common Retirement Fund reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • New York State Common Retirement Fund sold 57,831 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $1.59M.
  • New York State Common Retirement Fund first reported a position in Translate Bio, Inc. Common Stock in Q4 2018 and held it in 11 quarters.
  • New York State Common Retirement Fund's Translate Bio, Inc. Common Stock position peaked at $1.59M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.